Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Juanzhi, Fang"'
Autor:
Stewart J. Tepper, Juanzhi Fang, Pamela Vo, Ying Shen, Lujia Zhou, Ahmad Abdrabboh, Mrudula Glassberg, Matias Ferraris
Publikováno v:
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background Migraine is one of the leading causes of disability worldwide. Erenumab is a fully human monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) receptor. This study aimed to evaluate real-world evidence on the
Externí odkaz:
https://doaj.org/article/edb867d28064473db2f7c37ae16d9c26
The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 535-549 (2020)
Abstract Introduction Prior studies have estimated the burden of migraine in patients suffering from ≥ 4 monthly headache days (MHDs), but the burden experienced by migraineurs suffering from one to three (1–3) MHDs is unknown. The aim of this st
Externí odkaz:
https://doaj.org/article/4f7b17953f3f411a8a2d6aea2c55fa46
Autor:
Marieke M.B. Seyger, Matthias Augustin, Michael Sticherling, Teresa Bachhuber, Juanzhi Fang, James Hetherington, James Lucas, Sophie Meakin, Craig Richardson, Amy S. Paller
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
This study is a retrospective analysis using data collected from the Adelphi Paediatric Psoriasis Disease-Specific Programme cross-sectional survey. Despite being treated for their psoriasis, a substantial proportion of paediatric patients presented
Externí odkaz:
https://doaj.org/article/36a55a0d80b34c9faf6b102f7a2a1015
Autor:
Stewart J Tepper, Juanzhi Fang, Lujia Zhou, Pamela Vo, Ahmad Abdrabboh, Mrudula Glassberg, Matias Ferraris
Publikováno v:
Cephalalgia Reports, Vol 4 (2021)
Background: Erenumab, a fully human monoclonal antibody targeting the calcitonin gene-related peptide pathway, was developed specifically for preventive treatment of migraine. Objective: To compare the real-world effectiveness of erenumab and non-spe
Externí odkaz:
https://doaj.org/article/c34ea09e7919453a84bd75c1b089350f
Autor:
Claus F. Vogelmeier, Konstantinos Kostikas, Juanzhi Fang, Hengfeng Tian, Bethan Jones, Christopher Ll Morgan, Robert Fogel, Florian S. Gutzwiller, Hui Cao
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Blood eosinophil counts and history of exacerbations have been proposed as predictors of patients with chronic obstructive pulmonary disease (COPD) who may benefit from triple therapy (inhaled corticosteroid, long-acting β2-agoni
Externí odkaz:
https://doaj.org/article/6eea1febdec047c5b4f9ed7816ed7723
Publikováno v:
Pain and Therapy, Vol 8, Iss 2, Pp 203-216 (2019)
Abstract Introduction Migraine imposes a substantial burden on patients, society, and healthcare systems. This study aimed to assess the associations between the number of headache-free days (HFDs) and health-related quality of life (HRQoL), work pro
Externí odkaz:
https://doaj.org/article/03c422d92b524cef911966652f36a2b3
Autor:
Pamela Vo, Nicolas Paris, Aikaterini Bilitou, Tomas Valena, Juanzhi Fang, Christel Naujoks, Ann Cameron, Frederic de Reydet de Vulpillieres, Francois Cadiou
Publikováno v:
Neurology and Therapy, Vol 7, Iss 2, Pp 321-332 (2018)
Abstract Introduction Migraine is a neurological disease characterized by recurring attacks that can cause severe disabling pain. This study described the burden of migraine as reported by individuals with migraine in the real world using a mobile ap
Externí odkaz:
https://doaj.org/article/8f54d804afe04db09b3cb4d399474956
Publikováno v:
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background Migraine is a distinct neurological disease that imposes a significant burden on patients, society, and the healthcare system. This study aimed to characterize the incremental burden of migraine in individuals who suffer from ≥4
Externí odkaz:
https://doaj.org/article/ac5a87f12ff44dd186f41b635549dc3c
Autor:
Anthony Traboulsee, David K. B. Li, Mark Cascione, Juanzhi Fang, Fernando Dangond, Aaron Miller
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background In the PRISMS study, interferon beta-1a subcutaneously (IFN β-1a SC) reduced clinical and radiological disease burden at 2 years in patients with relapsing–remitting multiple sclerosis. The study aimed to characterize efficacy
Externí odkaz:
https://doaj.org/article/b6b1f99eb4d94bd39657e64b50aebd7f
Autor:
Anthony Traboulsee, David K. B. Li, Mark Cascione, Juanzhi Fang, Fernando Dangond, Aaron Miller
Publikováno v:
BMC Neurology, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background On-treatment magnetic resonance imaging lesions may predict long-term clinical outcomes in patients receiving interferon β-1a. This study aimed to assess the effect of active T2 and T1 gadolinium-enhancing (Gd+) lesions on relaps
Externí odkaz:
https://doaj.org/article/7e02cb599423484399ffbcdfb518ec8f